---
title: 'Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current
  Controversies and Challenges for Radiation Oncologists in 2024'
date: '2024-12-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39672636/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20241214171553&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Cutaneous T-cell lymphomas (CTCL) are a rare collection of diseases,
  frequently associated with diagnostic challenges and complex management dilemmas.
  The multidisciplinary team is vital for accurate clinico-pathological diagnoses
  and for collaborative therapeutic decisions throughout the management journey, which
  frequently involves multiple lines of therapy. Radiotherapy (RT) is a highly effective
  skin-directed therapy for CTCL, commonly delivered as localised fields or as total
  skin ...
disable_comments: true
---
Cutaneous T-cell lymphomas (CTCL) are a rare collection of diseases, frequently associated with diagnostic challenges and complex management dilemmas. The multidisciplinary team is vital for accurate clinico-pathological diagnoses and for collaborative therapeutic decisions throughout the management journey, which frequently involves multiple lines of therapy. Radiotherapy (RT) is a highly effective skin-directed therapy for CTCL, commonly delivered as localised fields or as total skin ...